Identification of the inhibitory FcγR involvement in the ADE process expands our understanding of the mechanisms of pathogenesis for a broad range of infectious diseases and opens approaches for improvement in the treatment and prevention of such diseases. This evidence concerns the gene FCGR2A and infectious disease.